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Abstract The structural features of the complexes that
K-bungarotoxin forms with three different synthetic peptides,
mimotopes of the nicotinic acetylcholine receptor binding site,
have been compared to the corresponding nuclear magnetic
resonance (NMR) and surface plasmon resonance (SPR) data.
For the considered peptides, the observed different affinities
towards the toxin could not be accounted simply by static
structural considerations. A combined analysis of the SPR- and
NMR-derived dynamic parameters shows new correlations
between complex formation and dissociation and the overall
pattern of intramolecular and intermolecular nuclear Overhauser
effects. These features could be crucial for a rational design of
protein ligands. ß 2002 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
Peptide and antigen fragment libraries obtained by the
phage display technology have been extensively used to study
antibody^antigen interaction in order to develop vaccines and
diagnostic tools. Moreover, the same technology has been
proposed, in general, for investigating any protein^protein
or peptide^protein interaction for the design of selective li-
gands of potential pharmaceutical interest [1].
Understanding the ¢ne details of these intermolecular pro-
cesses is crucial to design peptide ligands with improved af-
¢nity and activity. In this respect, it is now well established
that surface plasmon resonance (SPR) and nuclear magnetic
resonance (NMR) are playing a major role in elucidating dy-
namics and structural aspects of protein^protein and peptide^
protein complex formation. SPR yields accurate estimates of
kinetic parameters of the intermolecular interaction, such as
kon and koff , while NMR o¡ers precious information on the
structural stability of the complex by analyzing intramolecular
and intermolecular nuclear Overhauser e¡ects (NOEs).
A strong correlation between the structure stability and the
a⁄nity between protein subdomains has been found from
SPR data [2] and a combined use of SPR and NMR measure-
ments has been proposed for investigating peptide^antibody
[3,4] and virus^receptor interactions [5].
Among the various peptide^protein interactions, the
complex formation between acetylcholine receptor (AChR)
mimotopes and K-bungarotoxin (K-btx) has been analyzed
in detail both by SPR [6] and NMR [7,8,9]. Thus, the struc-
ture of three slightly di¡erent complexes are available in
the Protein Data Bank (PDB) with the 1JBD, 1HAA and
2BTX codes [10], where K-btx is bound respectively to the
peptides WRYYESSLKPYPD, HRYYESSLEPWYPD and
MRYYESSLKSYPD, henceforth called HaPep, p6.7 and
LLPep. In the present report the favorable opportunity to
discuss a good wealth of dynamic and structural data for
such similar molecular systems will be exploited in order to
correlate complex a⁄nity with structural features. A good
agreement of SPR derived KA values with IC50 and KA con-
ventional methods has been recently discussed for the inves-
tigated system [6]. The SPR characteristics of these mimotopes
and of some of their analogs will be also analyzed.
2. Materials and methods
The structural analysis of all the peptide^protein complexes was
carried out on the basis of the 3D models generated with the program
MOLMOL [11] for the corresponding PDB ¢les 1JBD, 1HAA and
2BTX. Molecular volumes and exposed surfaces were calculated ac-
cording to the Richards’ algorithm [12] with a probe radius of 1.4 Aî .
Peptides were synthesized on Rink Amide MBHA resin (Nova Bio-
chem) using 9-£uorenylmethoxycarbonyl chemistry on an automated
synthesizer (MutysynTech Syro); peptides were puri¢ed by high pres-
sure liquid chromatography and identity and purity of ¢nal products
was con¢rmed by electrospray ionization and matrix-assisted laser
desorption ionization mass spectrometry.
SPR measurements were performed on a BIACORE 1000 Up-
graded (BIACORE AB, Uppsala, Sweden). Biotin-conjugated^K-btx
was immobilized on a streptavidin-coated sensor chip by injecting the
toxin diluted in HEPES bu¡er saline (10 mM HEPES, 150 mM NaCl,
3.4 mM EDTA, 0.005% polysorbate 20, pH 7.4) (HBS; Biacore AB)
at a concentration of 10 Wg/ml at a £ow rate of 10 Wl/min. For kinetic
experiments, peptides diluted in HBS at concentrations ranging from
6.5 to 0.06 WM were injected at a £ow rate of 30 Wl/min over the
immobilized K-btx.
Association and dissociation kinetic rate constants (kon and koff )
and the equilibrium association constant KA were calculated using the
BIAevaluation 3.0 software [13].
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3. Results and discussion
A SPR analysis of K-btx binding kinetics has been per-
formed on a series of AChR peptide mimotopes in identical
experimental conditions (Fig. 1).
It is of primary interest the fact that the mimotope HaPep,
which has the highest biological activity in terms of IC50 [9],
experiences also the largest KA value, deriving mostly from its
very slow dissociation rate, see Fig. 1A. For p6.7 and HaPep,
indeed, similar kon rates were measured, suggesting that the
higher a⁄nity constant obtained for the latter mimotope can
be totally ascribed to the stability of the complex.
The peptide^protein association process, quantitatively
measured from SPR-derived kon data, has been analyzed
also with the aid of a series of p6.7 analogs. The N-terminus
acetylated derivative of p6.7, acHRYYESSLEPWYPD, to-
gether with a series of its analogs, progressively shortened at
the C-terminus up to a four-residue length, were analyzed in
BIACORE (Fig. 1B). The corresponding kon and koff values
are reported in the same ¢gure.
Three main features appear from these SPR data: (i) no
binding can be detected for peptides shorter than 11 residues,
(ii) the acetylation of the amino terminus determines a four-
fold reduction of the p6.7 rate, and (iii) within all the p6.7
analogs there is only a two-fold increase in the dissociation
rates and more than one order of magnitude in the association
decrease. The large observed changes in the association pro-
cess can be attributed to two distinct aspects. The ¢rst one is
related to the disappearance of the positive charge at the
amino terminus, due to its acetylation, and to the removal
of the hydrogen bond between H1NHD14p6:7ONp6:7 observed in
the K-btx/p6.7 complex structure [7]. This hypothesis suggests
that this molecular moiety could act as an anchor towards the
toxin binding site.
The second contribution to the observed association de-
crease may be determined by a reduced e⁄ciency of the prolyl
residue in position 10 as a folding inducer [7]. This explana-
tion is also consistent with the fact that the shorter is the
number of residues following this proline, the higher is its
£exibility. In this case, it is apparent that the capability of
this residue to induce the folding of the remaining part of
the peptide chain is reduced.
Some of the NMR-derived structural features, available for
K-btx complexed with AChR mimotopes, are summarized in
Table 1.
From the PDB entries 1JBD, 1HAA and 2BTX, which refer
to the average minimized structures of K-btx respectively com-
plexed with p6.7, HaPep and LLPep, rather di¡erent struc-
tural features can be observed, in spite of the close similarity
in the mimotope lengths and amino acid compositions. The
fact that, among the above mentioned structures, the K-btx/
p6.7 complex has the smallest volume and exposed surface
area (ESA) suggests that this complex has the most compact
conformation, also considering that p6.7 is one amino acid
longer than the other two mimotopes. This compactness, re-
ducing backbone £exibility, is fully consistent with the large
Fig. 1. A: SPR analysis of binding of peptide mimotopes p6.7,
LLPep and HaPep to K-btx. RU: Resonance unit. B: SPR analysis
of binding of progressively shortened derivatives of p6.7 to K-btx.
Peptides were injected over a BIACORE SA sensor chip where bio-
tinylated K-btx had been previously captured via streptavidin.
Table 1
Backbone heavy atoms RMSD calculated from the structure of the free K-btx (PDB code 1IK8); numbers in parentheses refer to the consid-
ered fragments
1JBD 1HAA 2BTX 1IK8
RMSD ¢nger I (5^12) 1.55 1.41 1.91 ^
RMSD ¢nger II (28^39) 1.65 2.41 1.63 ^
RMSD ¢nger III (50^60) 2.97 2.07 2.61 ^
RMSD carboxy terminus (70^74) 2.17 1.06 1.90 ^
ESA (Aî 2) 4921 4994 4970 4432
Protein^peptide contact area (Aî 2) 742 606 502 ^
Complex volume (Aî 3) 10025 11002 10863 ^
K-btx volume (Aî 3) 9406 9113 9020 8729
Peptide volume in the complex (Aî 3) 1937 1878 1761 ^
# long range intraprotein NOEs 759 245 291 368
# long range intrapeptide NOEs 27 12 7 ^
# intermolecular NOEs 57 92 62 ^
1JBD, 1HAA, 2BTX and 1IK8 are the PDB codes respectively of K-btx/p6.7, K-btx/HaPep, K-btx/LLPep complexes and of K-btx alone. The
numbers of the observed NOEs are taken from the corresponding references (see text).
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number of intramolecular NOEs detected for the peptide and
protein moieties in the K-btx/p6.7 complex.
Moreover, the calculated contact area between the toxin
and the mimotope in the K-btx/p6.7 complex results to be
larger than in the other two cases.
Thus, peptide^protein contact areas, ESAs, volumes and
number of intramolecular NOEs obtained for the three con-
sidered complexes seemed to predict a higher a⁄nity of p6.7
towards K-btx in respect to the other two mimotopes.
This hypothesis is fully discarded in light of the above dis-
cussed SPR results. It follows that complex stability, at least
for this molecular system, but very likely in general, is in£u-
enced not only by steric contributions, but also by dynamic
aspects.
The lowest koff value observed for K-btx/HaPep, a measure
of the molecular compatibility between the protein and the
peptide, is fully in agreement with the observation that the
largest number of intermolecular NOEs is found, by far, for
this complex.
Such a combined analysis of the SPR and NMR data o¡ers
interesting correlations, never discussed so far on the basis of
experimental data, between koff values and number of inter-
molecular NOEs, which seem to be precious to de¢ne further
details of the peptide^protein interaction process.
The fact that a reliable solution structure of the free K-btx is
now available [7] allows new correlations between toxin struc-
tural changes, induced by the complexation with the three
similar mimotopes, and the extent of the observed koff values.
A schematic view of K-btx conformational rearrangements
upon mimotope binding is given in Fig. 2. The toxin confor-
mational change can be quantitatively described by a RMSD
analysis of the positional parameters of the backbone heavy
atoms in the critical regions of the toxin in the presence and in
the absence of the complexed peptides. From the RMSD val-
ues reported in Table 1, it appears that the smallest conforma-
tional changes in the toxin ¢ngers I and III and in the carboxy
terminus backbone heavy atoms are induced by the HaPep
complex formation. In this case, therefore, a smaller energy
is required by K-btx to accommodate HaPep rather than p6.7
and LLPep. It should be noted also that in the case of K-btx/
HaPep, exhibiting the highest RMSD for ¢nger II, the re-
quired energy for these extensive conformational changes
may be well counterbalanced by a favorable elongation of
the toxin ¢nger II L-sheet structure, which involves four addi-
tional residues.
It can be concluded that, at least in the case of the consid-
ered K-btx^mimotope interactions, the complex stability can-
not be fully explained in terms of molecular compactness or
number of van der Waals and H bonding interactions.
From the analysis of the toxin conformational changes of
the three complexes and the corresponding kinetic parameters,
it can be suggested that entropic contributions may play a
relevant role. The reduced conformational freedom observed
for the K-btx carboxy terminus, when bound to LLPep and
p6.7 in respect to HaPep, seems to yield also a relevant con-
tribution of this type.
Thus, it is apparent that the here proposed SPR/NMR
combined approach o¡ers new possibilities to investigate
¢ne details of the peptide^protein interaction. These ¢ndings
can be exploited to design ligands with improved a⁄nity by
means of amino acid substitutions, which can be suggested by
the speci¢c roles exhibited by each residue separately in asso-
ciation and dissociation processes.
A⁄nity maturation of ligands, derived from peptide libra-
ries, on a rational structural and kinetic basis appears the
main application of our approach.
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Fig. 2. Superposition of minimized average structures of K-btx
bound to three di¡erent AChR mimotopes (not shown). Toxin
backbones of the complexes with p6.7, HaPep and LLPep are col-
ored respectively in purple, cyan and yellow; red-colored backbone
regions correspond to the aligned regions with the residues 3, 16^
23, 44^48 and 59^65.
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